HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

1,1,1,2,2- pentafluoro- 7- phenylheptan- 3- one

an iPLA2 GVIA inhibitor

Also Known As:

FKGK11

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Ketones: 2618
  - 1,1,1,2,2-pentafluoro-7-phenylheptan-3-one: 1
- Hydrocarbons: 1713
  - Halogenated Hydrocarbons: 42
    - Fluorinated Hydrocarbons: 4
      - Fluorocarbons: 1209
        1,1,1,2,2-pentafluoro-7-phenylheptan-3-one: 1

Experts

1.	Antalis, Caryl: 1 article (07/2011)
2.	Emerson, Robert: 1 article (07/2011)
3.	Li, Hui: 1 article (07/2011)
4.	Wei, Gang: 1 article (07/2011)
5.	Xu, Yan: 1 article (07/2011)
6.	Zhang, Sheng: 1 article (07/2011)
7.	Zhang, Zhong-Yin: 1 article (07/2011)
8.	Zhao, Zhanzhong: 1 article (07/2011)
9.	Zhao, Zhenwen: 1 article (07/2011)

Related Diseases

1.	Neoplasms (Cancer) 07/01/2011 - "BEL and FKGK11 reduced adhesion, migration, and invasion of EOC cells in vitro; the reduced ability to adhere, migrate, and invade seems to increase the vulnerability of tumor cells to PTX. " 07/01/2011 - "Another iPLA(2) inhibitor, FKGK11, also inhibited tumor development in the xenograft mouse model, supporting that the major target of action was iPLA(2). "

Related Drugs and Biologics

1.	Calcium-Independent Phospholipases A2